Indivior Pharmaceuticals Inc
INDV
Pozycja w akcjach
#3878
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Cena akcji
$34.01
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$4.24B
Zmiana (1 dzień)
4.81%
Zmiana (1 rok)
40.02%
Kraj
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategoria
Healthcare
Zyski dla Indivior Pharmaceuticals Inc (INDV)
Zyski w Jun 2026 TTM: $393.00M
Według najnowszych raportów finansowych Indivior Pharmaceuticals Inc, obecny zysk firmy wynosi $393.00M. W roku 2023 firma osiągnęła zysk w wysokości $-149.00M, spadek w porównaniu do zysku z roku 2022, który wynosił $-89.00M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Indivior Pharmaceuticals Inc od 2016 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $393.00M | 2,707.14% |
| 2024 | $14.00M | -109.40% |
| 2023 | $-149.00M | 67.42% |
| 2022 | $-89.00M | -146.84% |
| 2021 | $190.00M | -209.83% |
| 2020 | $-173.00M | -196.11% |
| 2019 | $180.00M | -32.21% |
| 2018 | $265.53M | 84.52% |
| 2017 | $143.91M | 60.35% |
| 2016 | $89.75M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 349.00% |
IN
|
